TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05709249: Efficacy of Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Stage IIIB/IIIC Colon Cancer：a Study Protocol for a Randomized Controlled Trial

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 730 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$20,993,280

Rescue Site Savings

+$13,842,444

Unlock Full NCT05709249 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05709249 Rescue Dossier →